Regulatory and scientific communications firm PharmApprove has opened a European office and appointed Coos De Graaf to lead its operations in the region.
De Graaf, who joins as principal for commercial operations in Europe, has more than 30 years’ experience in pharma, including numerous roles in senior management.
He moves to PharmApprove, a New Jersey, US-headquartered division of Taft and Partners, from Solvay Pharmaceuticals, where he led various functions, including global compliance and clinical and commercial development.
The opening of a European office signals, said PharmApprove, “a new push towards expanded services and geographic markets”. Under De Graaf’s leadership, PharmApprove will continue to support clients preparing to bring new therapeutic agents and devices before assessment agencies.
“PharmApprove has established client experience in Europe, but adding a leader of Coos De Graaf’s calibre positions us extremely well to continue growing to serve our clients globally,” said PharmApprove president Laurie Smaldone.
“In addition we are excited to announce expanded services building upon our success in supporting product approvals to include market access communication support.”
Along with expanding its services, PharmApprove has outlined three key areas of focus: advisory committee preparation, regulatory communication and market access communications support.